Corporate Corruption News Stories
Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
If you count all the contracts for private industry from U.S. Customs and Border Protection (CBP) and U.S. Immigration and Customs Enforcement (ICE) since Joe Biden took office — for, that is, 2021, 2022, and 2023 — the number comes to $23.5 billion. And though you’d never guess it, given what we normally hear, that already beats Donald Trump’s total for his full four years in office, $20.9 billion. Or, to put the matter in a more historical perspective, private contracts for the Biden years already top the cumulative $22.5 billion spent in border and immigration enforcement budgets from 1975 to 1997. Budgets and private-sector contracts tell an all-too-familiar story in which the border-enforcement apparatus only continues to grow ever larger, regardless of who’s president. As 2023 nears its end, there have simply never been as many opportunities to make a killing (figuratively as well as literally) by surveilling, arresting, caging, and expelling people from this country. In 2023, there were 8,033 such opportunities — and I’m speaking here about contracts in play — or about 22 contracts a day. 1,421 remains of dead people were recovered along the border during Biden’s first two years in office, higher in other words than the 1,133 during Trump’s full four years. Imagine the national news stories, if the remains of nearly 1,500 hikers had been found in the Southwest during a two-year period. But for migrants in those ever more profitable, ever deadlier borderlands, mum’s the word.
Note: Carlos Arellano is a whistleblower and former immigration contractor, who alleges that the US government is the largest trafficker of children in the world. Watch an interview of Arellano share his shocking experiences at some of the immigration facilities. For further exploration of this troubling topic, read about MVM Inc, the ex-CIA defense contractor making millions of dollars hauling children away from the Mexico border on commercial airline flights. Where is the transparency about what is happening to these children?
Pfizer-BioNTech delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants until after the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the product. The vaccine makers also failed to account for a large number of subjects who dropped out of the trial. Together, these strategies kept regulators and the public ignorant of a 3.7-fold increase in cardiac deaths among subjects who received the vaccine, according to analysis in the International Journal of Vaccine Theory, Practice, and Research. Investigators looked at each of the 38 deaths occurring between July 27, 2020, the start of phase 2/3 of the Pfizer-BioNTech vaccine trial, and March 13, 2021, the end date culminating in Pfizer-BioNTech’s 6-month interim report. This trial phase involved 44,060 subjects. Half received a dose of BNT162b2, half got a placebo. The trial was unusual because at week 20 after the FDA issued the EUA for the vaccine, trial subjects in the placebo group were allowed to switch to the vaccinated group and receive their first BNT162b2 shot. Of 20,794 unblinded placebo subjects in the Pfizer trial, 19,685 received at least one dose of BNT162b2. After 33 weeks the data revealed no significant difference between deaths in the vaccinated and placebo groups for the initial 20-week placebo-controlled portion of the trial. 79% of relevant deaths were not recorded in time to be included in Pfizer’s regulatory paperwork.
Note: Read our recent essay on Big Pharma corruption to further explore the significant harms associated with the COVID vaccine. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and coronavirus vaccines from reliable major media sources.
The Oxford-AstraZeneca Covid-19 vaccine has been branded “defective” in a multi-million pound landmark legal action that will suggest claims over its efficacy were “vastly overstated”. The pharmaceutical giant is being sued in the High Court in a test case by Jamie Scott, a father-of-two who suffered a significant permanent brain injury that has left him unable to work as a result of a blood clot after receiving the jab in April 2021. A second claim is being brought by the widower and two young children of 35-year-old Alpa Tailor, who died after having the jab made by AstraZeneca. The test cases could pave the way for as many as 80 damages claims worth an estimated £80 million over a new condition known as Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) that was identified by specialists in the wake of the AstraZeneca Covid-19 vaccine rollout. In the months following the rollout, the potential serious side effect of the AstraZeneca jab was identified by scientists. Following this, it was recommended it no longer be given to the under-40s in the UK because the risk of receiving the jab outweighed the harm posed by Covid. Official figures ... show at least 81 deaths in the UK are suspected to have been linked to the adverse reaction that caused clotting in people who also had low blood platelets. Victims and their lawyers question the Government’s monitoring of the rollout and point out that ... Germany suspended the vaccine’s use for the under 60s at the end of March 2021.
Note: In the US, when current and former FDA advisers and academics asked the FDA to improve COVID vaccine labeling given the risk of severe vaccine injuries, the agency denied almost every single request. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Anti-vaccine advocates have recently made allegations against the Pfizer COVID-19 vaccine in hopes that the charges may hurt the drug manufacturer. In a series of posts on X (formerly Twitter), Steve Kirsch expressed concern over reports that Pfizer's vaccine was contaminated, saying that the Food and Drug Administration (FDA) "is now at a crossroads." "Either they admit that they knew about the plasma contamination, and failed to disclose that to the public and to the outside committees, or they can claim that they didn't know about it in which case Pfizer is liable. But we have the Pfizer documents that were given to the FDA so we know what the FDA got," Kirsch wrote. "I seriously doubt there's any disclosure of SV40 contamination. That means we have an adulterated vaccine and the FDA has to remove it from the market until the adulteration is fixed. If the FDA doesn't do that, they should face criminal prosecution for endangering the public, and not following the law." (SV40 refers to simian virus 40.) In his posts, Kirsch also references an incident in Michigan where a judge ruled that the manufacturer of the COVID-19 medication Remdesivir was no longer protected by the federal Public Readiness and Emergency Preparedness (PREP) Act after a man filed a lawsuit against the manufacturer. The man filed the suit after suffering strokes and an amputation following treatment with the drug, Remdesivir, which was contaminated with glass particles.
Note: While the data is still being uncovered, read an in-depth, scientific investigation into vaccine contamination, including concerns that Pfizer hid this contamination from regulators. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Some of the experts responsible for helping to craft the U.S. dietary guidelines also take money from big food and drug companies. A report ... by the nonprofit U.S. Right to Know makes those concerns plain. Nine of the 20 experts on the 2025 Dietary Guidelines Advisory Committee have had conflicts of interest in the food, beverage, pharmaceutical or weight loss industries in the last five years, the report found. Gary Ruskin, the executive director of the nonprofit, said the finding “erodes confidence in the dietary guidelines,” which provide recommendations on how people can eat a healthier diet. The guidelines are widely used by policymakers to set priorities in federal food programs, health care and education. Questions about industry influence could damage the public’s trust that the recommendations are based in science. When committee members receive funding from certain industry groups or organizations, it raises the concern that they may be biased, Dr. [Marion] Nestle said. “Part of the problem is the influence is unconscious,” she said. “People don’t recognize it,” she added, and will often deny it. Even if such relationships do not influence the experts, Mr. Ruskin said, they can create the appearance that they do — which can seed doubt about how independent the committee’s recommendations actually are. Industry influence can [also] creep in later in the process ... when the U.S.D.A. and the H.H.S. produce the final guidelines based on the committee’s advice.
Note: U.S. Right to Know is an excellent resource for investigating how the food industry shapes science, policy and public opinion. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
There’s a hidden ingredient used as a whitener in an array of foods. It’s called titanium dioxide, and while commonly used in the US, it’s being banned in the EU as a possible carcinogen. The additive, also known as E171, joins a host of other chemicals that are banned in foods in the European Union but allowed in the US. These include Azodicarbonamide, a whitening agent found in food such as breads, bagels, pizza, and pastries in the US, which has been banned in the EU for more than a decade. The additive has been linked to asthma and respiratory issues in exposed workers and, when baked, to cancer in mice studies. The Food and Drug Administration classifies these food chemicals, and many others prohibited by the EU, as “generally recognized as safe”. Chemical safety processes in the EU and US work in starkly different ways. Where European policy tends to take a precautionary approach – trying to prevent harm before it happens – the US is usually more reactive. And while the EU has consistently updated its methods and processes for evaluating new chemicals, some experts say the US system, set up more than half a century ago, needs updating. In the case of additives like titanium dioxide, manufacturers petition the FDA for its approval by submitting evidence that the substance is safe for its intended use. The FDA evaluates the application, and will authorize the additive if it concludes the data provided demonstrates that the substance is safe to use.
Note: Unlike other countries, the U.S. is known to raise objections to the regulation of toxic chemicals in our food, with its regulatory agencies having deep financial ties to powerful food and agrichemical industries. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
The United Nations has warned that there was “clear evidence” that war crimes may have been committed in “the explosion of violence in Israel and Gaza”. Meanwhile, Wall Street is hoping for an explosion in profits. During third-quarter earnings calls this month, analysts from Morgan Stanley and TD Bank took note of this potential profit-making escalation in conflict and asked unusually blunt questions about the financial benefit of the war between Israel and Hamas. TD Cowen’s Cai von Rumohr, managing director and senior research analyst specializing in the aerospace industry, [asked] about the upside for General Dynamics, an aerospace and weapons company in which TD Asset Management holds over $16m in stock. The aerospace and weapons sector ... enjoyed a 7-percentage point jump in value in the immediate aftermath of Hamas’s 7 October attack on Israel and the beginning of Israel’s bombardment of Gaza. “Hamas has created additional demand, we have this $106bn request from the president,” said Von Rumohr, during General Dynamics’ earnings call on 25 October. “Can you give us some general color in terms of areas where you think you could see incremental acceleration in demand?” Aside from the callousness of casually discussing the financial benefits of far-off armed conflict, the comments raise questions about whether these major institutional shareholders of weapons stocks are abiding by their own human rights policies.
Note: For more along these lines, see concise summaries of deeply revealing news articles on war and corporate corruption from reliable major media sources.
Ever since Israel responded to Hamas’s atrocities with a vicious onslaught that has killed more than 8,000 Palestinians there has been an attempt to silence, intimidate and harass Palestinian sympathisers. Inevitably, it is Palestinians who suffer the brunt of a campaign to stigmatise even the most basic opposition to the mass slaughter of their people. Viet Thanh Nguyen, the son of refugees and a sympathiser with other displaced people, had a talk at the 92nd Street Y centre in New York postponed after he signed an open letter demanding an “end to the violence and destruction in Palestine”. What of the US Campaign for Palestinian Rights, whose longstanding conference in Houston was cancelled following the Orthodox Jewish Chamber of Commerce describing the event as “a conference for Hamas supporters”? The Hilton cited security concerns as the reason for the cancellation. The keynote speaker, Rashida Tlaib, the first ever elected Palestinian-American congresswoman, has been targeted by a Republican smear campaign, with an attempt to censure her for “antisemitic activity” and “sympathising with terrorist organisations” – all baseless attacks. Meanwhile, MSNBC reportedly stopped three of its Muslim broadcasters from presenting their shows, with no explanation. The broadcaster claimed any change in programming as “coincidental”. This intimidation has deadly consequences: it undermines public pressure on Israel’s western allies to stop the slaughter and end the occupation.
Note: For more along these lines, see concise summaries of deeply revealing news articles on war and media manipulation from reliable sources.
Nearly three months into taking Ozempic for diabetes, Jenny Kent had already lost 12 pounds, and her blood sugar numbers were looking better than they had in a while. Ozempic, the injectable drug approved for Type 2 diabetes, has taken the world by storm. Despite not being approved by the Food and Drug Administration for weight loss, Ozempic has prompted people on TikTok and Instagram to speculate about which stars have used it to shed pounds seemingly overnight. But for Kent something else changed after she started taking Ozempic. "I was just constantly in a state of being overwhelmed," says Kent. "So my response to that was just I was just crying all the time. Sobbing, crying ... I still didn't put it together, so I kept ... taking my injections." She's one of many people taking Ozempic and related drugs who describe mental health problems. But that side effect isn't mentioned in Ozempic's instructions for use, or drug label. In July, the European Medicines Agency said that it was looking into the risk of thoughts of self-harm and suicidal thoughts with the use of Ozempic and similar drugs. The FDA hasn't taken that step. NPR analyzed the FDA's adverse event reporting system, or FAERS, and learned that the agency has received 489 reports of patients experiencing anxiety, depression or suicidal thoughts while taking semaglutide drugs, including Ozempic, Wegovy and Rybelsus. In 96 of those reports, the patient had suicidal thoughts. Five of them died.
Note: A deeper investigation explores the concerning scope of health issues related to weight-loss drug side effects. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Companies that make popular weight loss shots like Ozempic and Mounjaro are starting to test a version for kids as young as six years old who suffer from obesity. Pharmaceutical company Eli Lilly signaled its plans to start clinical trials with Mounjaro for kids ages 6-11, over the weekend. Novo Nordisk, the company that makes Ozempic, reported it is in phase three of testing Saxenda, a version of its drug for children ages 6-12. The rates of obesity for children in the U.S. have tripled since the 1980s, affecting close to 15 million children nationwide, according to the CDC. This is nearly one in five kids. “It’s unlikely it’s going to do much if you just give them the medication. You need to instill all these behavior changes, lifestyle changes, talk about the diet, nutrition consults, the exercise,” said pediatrician Dr. Alison Mitzner. The concern for possible long-term impacts and side effects is one nutritionist Carrie Lupoli echoes. Both drug companies were sued earlier this year after a plaintiff said she suffered stomach paralysis. “It’s scary to me that we are going down that path instead of actually working on the root cause because we know weight gain is a symptom of health and hormones,” Lupoli said. CDC data shows kids may have gained weight twice as fast during the pandemic. Earlier this year, the American Academy of Pediatrics came out with new guidance that includes medication and surgery as suggestions for patients 12 and up suffering from obesity.
Note: The pharmaceutical companies behind these weight loss drugs are raking it in despite significant efficacy and safety concerns. Sales of Ozempic generated revenue of $3.2 billion in the second quarter (up from $2.1 billion during the same period in 2022) and Mounjaro generated $980 million in sales for the company during the second quarter (a 72% increase compared to the first quarter). For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
While I was out of town on business, I got a call from my dad who told me my husband Woody had been found hanging—dead at age 37. Woody wasn’t depressed and he hadn’t had a history of depression nor any other mental illness. His doctor had prescribed the antidepressant Zoloft to take the edge off. In the following weeks, I started to investigate, to try and understand why my perfectly normal husband had decided to end his life. The only thing that made sense ... Zoloft. Figuring out Zoloft’s dangers completely altered my life’s trajectory, absorbing years of my time. Today, I sit on one of the Food and Drug Administration (FDA) advisory committees that reviews new drugs coming to market. I initially thought that what I was learning about Zoloft was just an isolated issue with antidepressants. But I soon realized it was part of a much bigger, systemic problem with our nation’s drug safety system. The pharmaceutical industry is driven by commercial interests, not public health, and this problem is compounded by a lack of transparency, conflicts of interests, manipulation of clinical trials, and undue corporate influence across the government. Marketing companies ghostwrite pharmaceutical studies for academics who sometimes barely read the papers that get submitted to medical journals, and drug makers then cite these ghostwritten studies as peer-reviewed proof of their products’ safety and efficacy. The revolving door between Big Pharma and the FDA spins faster than the one between the Pentagon and the defense industry.
Note: This guest essay is written by Kim Witczak, a globally renowned advocate for pharmaceutical drug safety and FDA reform. Antidepressants have been found to increase the risk of suicide in some patients. For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma corruption from reliable major media sources.
A new study published in JAMA Psychiatry finds that almost everyone will be treated for mental illness at some point in their lives and that their lives are worse in many ways after receiving diagnosis and treatment. About 80% of the population will be hospitalized or receive psychiatric drugs. After treatment, they are more likely to end up poor, unemployed, and receiving disability benefits, and they have worsening social connections. According to the researchers, the likelihood of getting prescribed psychiatric drugs during your lifetime was 82.6% (87.5% for women and 76.7% for men). The likelihood of being hospitalized for mental illness was 29.0% (31.8% for women and 26.1% for men). On average, the 80% who were treated for mental illness were already struggling before treatment. But after treatment, things only got worse. After treatment, “individuals with any mental health disorder were more likely to experience new socioeconomic difficulties, compared with control individuals from the general population,” the researchers write. “During follow-up, they were more likely to become unemployed or receive a disability benefit, to earn lower income, to be living alone, and to be unmarried.” There is copious evidence that antidepressant use leads to worse outcomes in the long term, even after controlling for the severity of depression and other factors. The adverse effects of the drugs lead to worse health outcomes for those taking them, and withdrawal symptoms prevent people from being able to discontinue.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
Policing expenses mount quickly: $18,000 for technology to unlock cellphones in Southington, Conn.; $2,900 for surveillance cameras and to train officers and canines in New Lexington, Ohio. And in other communities around the country, hundreds of thousands for vehicles, body scanners, and other equipment. State and local governments are turning to a new means to pay those bills: opioid settlement cash. This money — totaling more than $50 billion across 18 years — comes from national settlements with more than a dozen companies that made, sold, or distributed opioid painkillers, including Johnson & Johnson, AmerisourceBergen, and Walmart, which were accused of fueling the epidemic that addicted and killed millions. In August, more than 200 researchers and clinicians delivered a call to action to government officials in charge of opioid settlement funds. "More policing is not the answer to the overdose crisis," they wrote. Years of research suggests law enforcement and criminal justice initiatives have exacerbated the problem. "Police activity is actually causing the very harms that police activity is supposed to be stemming," says Jennifer Carroll, an author of that study and an addiction policy researcher. In Louisiana ... 80% of settlement dollars are flowing to parish governments and 20% to sheriffs' departments. Over the lifetime of the settlements, sheriffs' offices in the state will receive more than $65 million — the largest direct allocation to law enforcement nationwide. And they do not have to account for how they spend it.
Note: Explore past news articles we've summarized on opioids, a crisis fueled by US drug companies and captured government agencies. For more along these lines, see concise summaries of deeply revealing news articles on police corruption from reliable major media sources.
A recent court ruling in Colorado highlighted how Google’s tracking of our locations and web searches helps police find suspects when they have few leads — but it’s also sweeping innocent people into investigations. Google says it has procedures to “protect the privacy of our users while supporting the important work of law enforcement.” But defense attorneys and civil liberties advocates say that Google is a gold mine for novel police methods that they call unconstitutional fishing expeditions. Even if you believe you have nothing to hide from law enforcement, relentless digital tracking of Americans risks our information falling into criminals’ hands, too. Law enforcement officials say that Google’s data on people’s locations and search histories helps solve crimes, including in the 2021 Capitol riot. In initial court-ordered warrants to Google, the company typically gives police information that isn’t connected to people’s identity. Only after they single out potentially suspicious data do the police go back for individually identifiable information. But defense lawyers and privacy advocates say the two types of broad warrants to Google turn normal police work upside down and threaten Americans’ rights. In a typical search warrant, police have a suspect in mind and ask for a judge’s approval to search their home, phone data and other potential evidence. In the large-scale search term and location warrants, police know a crime occurred but don’t know who might have committed it.
Note: Explore news articles we've summarized on the troubling nature of the use of location tracking by governments and corporations. For more along these lines, see concise summaries of deeply revealing news articles on police corruption and the disappearance of privacy from reliable major media sources.
The Washington Post has published at least four long articles dismissing the censorship revealed by the Twitter Files and Missouri v. Biden lawsuit, which is headed to the Supreme Court. By contrast, in its story on the censorship of pro-Palestinian voices, the Washington Post expresses great skepticism of Big Tech and sympathy for the people censored — the exact opposite of how it treated the issue when it was non-Leftists who were being censored. To be sure, there has been a concerning increase in demands for censorship and blacklisting since the October 7 Hamas attacks. New York University appears to be investigating a student who said, “Israel bears full responsibility for this tremendous loss of life.” But the alarm that the news media are raising is in striking contrast to the indifference ... to the evidence of governmental and nongovernmental censorship of a variety of disfavored views and voices relating to climate change, Covid, Ukraine, and the Biden family’s influence-peddling. Media outrage about censorship of pro-Palestinian voices sent social media platforms scrambling in order to end the censorship. The Washington Post’s queries forced at least one social media company to stop censoring. “After The Washington Post sent questions to TikTok about the video, the sound was restored.” A Meta spokesperson said a “bug” had caused some of the trouble. “We fixed a problem that briefly caused inappropriate Arabic translations in some of our products,” the statement said.
Note: For more along these lines, see concise summaries of deeply revealing news articles on media corruption from reliable sources.
More than 80 percent of four-star officers retiring from the U.S. armed forces go on to work in the defense industry, a new study has found, underscoring the close relationship between top U.S. brass and government-contracted companies. Twenty-six of 32 four-star admirals and generals who retired from June 2018 to July 2023 were later employed in roles including executive, adviser, board member or lobbyist for companies with significant defense business, according to the analysis from the Quincy Institute for Responsible Statecraft, a think tank that advocates restraining the military’s role in U.S. foreign policy. “The revolving door between the U.S. government and the arms industry, which involves hundreds of senior Pentagon officials and military officers every year, generates the appearance — and in some cases the reality — of conflicts of interest in the making of defense policy and in the shaping of the size and composition of the Pentagon budget,” authors William Hartung and Dillon Fisher wrote. The findings shed new light on a phenomenon examined in a 2021 report from the Government Accountability Office, which found that 14 major defense contractors ... employed 1,700 former senior officials or acquisition officials in 2019. The GAO concluded that while defense contractors benefit from the practice, it could “affect public confidence in the government” by creating a perception that military officials may favor a company they see as a future employer.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in the military and in the corporate world from reliable major media sources.
Silicon Valley techies are pretty sanguine about commercial surveillance. But they are much less cool about government spying. Government employees and contractors are pretty cool with state surveillance. But they are far less cool with commercial surveillance. What are they both missing? That American surveillance is a public-private partnership: a symbiosis between a concentrated tech sector that has the means, motive, and opportunity to spy on every person in the world and a state that loves surveillance as much as it hates checks and balances. The tech sector has powerful allies in government: cops and spies. No government agency could ever hope to match the efficiency and scale of commercial surveillance. Meanwhile, the private sector relies on cops and spies to go to bat for them, lobbying against new privacy laws and for lax enforcement of existing ones. Think of Amazon’s Ring cameras, which have blanketed entire neighborhoods in CCTV surveillance, which Ring shares with law enforcement agencies, sometimes without the consent or knowledge of the cameras’ owners. Ring marketing recruits cops as street teams, showering them with freebies to distribute to local homeowners. Google ... has managed to play both sides of the culture war with its location surveillance, thanks to the “reverse warrants” that cops have used to identify all the participants at both Black Lives Matter protests and the January 6 coup. Distinguishing between state and private surveillance is a fool’s errand.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the disappearance of privacy from reliable major media sources.
As war in Ukraine continues, controversial defense contractors and adjacent companies like Palantir, Anduril, and Clearview AI are taking advantage to develop and level-up controversial AI-driven weapons systems and surveillance technologies. These organizations’ common link? The support of the controversial, yet ever-more powerful Silicon Valley billionaire Peter Thiel. Thiel-backed groups’ involvement in war serves to develop not only problematic and unpredictable weapons technologies and systems, but also apparently to advance and further interconnect a larger surveillance apparatus formed by Thiel and his elite allies’ collective efforts across the public and private sectors, which arguably amount to the entrenchment of a growing technocratic panopticon aimed at capturing public and private life. What’s more, Thiel’s funding efforts signal interest in developing expansive surveillance technologies, especially in the name of combatting “pre-crime” through “predictive policing” style surveillance. As an example, Thiel’s provided significant funds to Israeli intelligence-linked startup Carbyne911 (as did Jeffrey Epstein), which develops call-handling and call-identification capacities for emergency services, and has ... a predictive-policing component. Thiel also assisted in the development and subsequent privatized spinoffs of the US Government’s Defense Advanced Research Projects Agency’s (DARPA) Total Information Awareness project.
Note: Peter Thiel was also recently reported to be an FBI informant. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.
Every year, up to 9,000 people die in the US as a result of a prescription medication error. That figure doesn’t include the hundreds of thousands of patients who suffer adverse effects from taking the wrong medication or taking meds in the wrong way. Now, an investigative report from the Los Angeles Times reveals that pharmacies make an estimated 5 million errors every year in California alone, according to the state’s Board of Pharmacy. But even as pharmacy errors mount across the US, pharmaceutical lobbyists are pushing to keep reports of errors hidden from officials and the public. The problem, according to pharmacists and others, is most acute at big retail pharmacy chains such as CVS and Walgreens, where overworked staff are pushed to the limit to meet sales quotas, despite desperate staffing shortages. To combat the rising tide of pharmacy errors, the California State Board of Pharmacy is sponsoring a bill that would require pharmacies to report every error to a third party outside the government. The bill would also allow the pharmacist responsible for the store to increase staffing if the workload has become too overwhelming to keep patients safe. But the bill is opposed by the California Community Pharmacy Coalition, a lobbying group representing retail pharmacies, including the big chains. The coalition believes pharmacy staffing requirements are too strict and it does not want the pharmacy board to have access to the error reports.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and Big Pharma profiteering from reliable major media sources.
Over 30 million Americans a year use benzodiazepines, or “benzos,” including Xanax, Valium, Ativan and Klonopin. Benzodiazepines are prescribed to treat anxiety disorders, insomnia, muscle spasms, schizophrenia, bipolar disorder, seizures and epilepsy. But this widely used class of drugs is linked to severe side effects and life impacts that can last for years — even after people have stopped taking the drugs — a new study finds. “Patients have been reporting long-term effects from benzodiazepines for over 60 years. I am one of those patients,” Dr. Christy Huff, a cardiologist and co-author of the study, said in a news release. The new research, published in PLOS One, includes a lengthy list of side effects that a majority of benzo users experienced more than a year after they stopped taking the drugs. Those long-lasting symptoms include low energy, difficulty focusing, memory loss, anxiety, insomnia, sensitivity to light and sounds, digestive problems, symptoms triggered by food and drink, muscle weakness and body pain. Alarmingly, users also struggled with severe life impacts: 54.7% reported suicide attempts or suicidal thoughts, for example. Health experts noted numerous other problems with benzos, including an increased risk of suicide and dependence on the drug, among other adverse side effects. Withdrawal from benzos can produce troubling symptoms as soon as within 24 hours, and these adverse effects can last for months.
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
